Megan D. Montgomery, Ph.D. - Publications
Affiliations: | 2009 | University of Nebraska Medical Center, Omaha, NE, United States |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2010 | Montgomery MD, Bylund DB. Lack of effect of the alpha2C-adrenoceptor Del322-325 polymorphism on inhibition of cyclic AMP production in HEK293 cells. British Journal of Pharmacology. 159: 820-30. PMID 20128806 DOI: 10.1111/J.1476-5381.2009.00584.X | 0.457 | |||
2007 | Bylund DB, Kozisek ME, Montgomery MD, Reed AL. Today's research, tomorrow's health: focus on pharmacogenomics. Personalized Medicine. 4: 363-367. PMID 29788667 DOI: 10.2217/17410541.4.3.363 | 0.386 | |||
2007 | Deupree JD, Montgomery MD, Bylund DB. Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram. European Journal of Pharmacology. 576: 55-60. PMID 17850785 DOI: 10.1016/J.Ejphar.2007.08.017 | 0.447 | |||
2007 | Montgomery MD, Taylor CK, Deupree JD, Bylund DB. Effect of alpha‐2C adrenergic receptor Del322‐325 polymorphism on cyclic AMP production in HEK293 cells The Faseb Journal. 21. DOI: 10.1096/fasebj.21.5.a423-c | 0.444 | |||
Show low-probability matches. |